Skip to main content
SpringerLink
Log in

Traitement endovasculaire et sclérose en plaques

  • Chapter
Thérapeutiques endovasculaires des pathologies veineuses

  • 1040 Accesses

Résumé

La remise en valeur des atteintes veineuses dans la sclérose en plaques (SEP) par la théorie de l’insuffisance veineuse cérébro- spinale (CCSVI) a fait naître un espoir immense parmi tous les patients atteints, relayé par les forums du Net, espoir souvent déçu à l’origine de comportements inadaptés, difficiles à maîtriser. Elle a entraîné une multiplication des actes interventionnels par des opérateurs inexpérimentés en pathologie veineuse, attirés par la fréquence de cette maladie. Des établissements centrés sur la prise en charge diagnostique et thérapeutique des atteintes veineuses dans la SEP ont vu le jour, appuyés par des publicités spectaculaires via Internet.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Frohman EM, Racke MK, Raine CS (2006) Multiple sclerosis — the plaque and its pathogenesis. N Engl J Med 354: 942–55

    Article  PubMed  CAS  Google Scholar 

  2. De Jager PL, Jia X, Wang J et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 41: 776–82

    Article  PubMed  Google Scholar 

  3. Ascherio A, Munger K (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 61: 288–99

    Article  PubMed  Google Scholar 

  4. Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol. 61: 504–13

    Article  PubMed  CAS  Google Scholar 

  5. Jones JL, Coles AJ (2010) New treatment strategies in multiple sclerosis. Exp Neurol 225: 34–39

    Article  PubMed  Google Scholar 

  6. Charcot (1868) Histologie de la sclérose en plaques. Gaz Hopit Civils Milit. 41: 554–566

    Google Scholar 

  7. Rindfleisch (1863). Histologisches detail zu der grauen degeneration von gehirn und rueckenmark. Arch. Path. Anat. Physiol. Klin. Med. 26: 474

    Article  Google Scholar 

  8. Putnam TJ (1937) Lesions of “Encephalomyelitis” and Multiple Sclerosis: Venous Thrombosis as the Primary Alteration, J. A. M. A. 108:1477–1480

    Article  Google Scholar 

  9. Losy J, Niezgoda A, Wender MJ (1999) Increased serum levels of soluble PECAM-1 i multiple sclerosis patients with brain gadolinium-enhancing lesions Neuroimmunol. 99: 169–72

    Article  CAS  Google Scholar 

  10. Minagar A, Jy W, Jimenez JJ, Alexander JS (2006) Neurol Res. 2006 Multiple sclerosis as a vascular disease Neurol Res. 28: 230–5

    Article  PubMed  CAS  Google Scholar 

  11. Fainardi E, Castellazzi M, Bellini T et al. (2006) Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Multiple Sclerosis 12: 294–301

    Article  PubMed  CAS  Google Scholar 

  12. Adams CW, Poston RN, Buk SJ (1989) Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci 92: 291–306

    Article  PubMed  CAS  Google Scholar 

  13. Adams CW (1988) Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry 51: 260–5

    Article  PubMed  CAS  Google Scholar 

  14. Fog T (1965) The topography of plaques in multiple sclerosis with special reference to cerebral plaques. Acta Neurol Scand Suppl 15: 1–161

    PubMed  CAS  Google Scholar 

  15. Schelling F (1986) Damaging venous reflux into the skull or spine: relevance to multiple sclerosis. Med Hypotheses 21: 141–148

    Article  PubMed  CAS  Google Scholar 

  16. Kermode AG, Thompson AJ, Tofts P et al. (1990) Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenic and clinical implications. Brain 113: 1477–89

    Article  PubMed  Google Scholar 

  17. Kwon EE, Prineas JW (1994) Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study. J Neuropathol Exp Neurol. 53: 625–36

    Article  PubMed  CAS  Google Scholar 

  18. Zamboni P (2006) The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med. 99: 589–93

    Article  PubMed  Google Scholar 

  19. Zamboni P, Menegatti E, Galeotti R et al. (2009) The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci. 282(1-2): 21–7

    Article  PubMed  Google Scholar 

  20. Zamboni P, Galeotti R, Menegatti E et al. (2009) Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 80: 392–9

    Article  PubMed  CAS  Google Scholar 

  21. San Millan Ruiz, D, Gailloud P, Rufenacht DA et al. (2002). The craniocervical venous system in relation to cerebral venous drainage. AJNR Am. J. Neuroradiol 23: 1500–08

    Google Scholar 

  22. Braun JP, Tournade A (1977). Venous drainage in the craniocervical region. Neuroradiology 13: 155–58

    Article  PubMed  CAS  Google Scholar 

  23. Ibukuro K, Fukuda H, Mori, K et Inoue Y (2001). Topographic anatomy of the vertebral venous system in the thoracic inlet. AJR Am. J. Roentgenol 176: 1059–65

    Article  PubMed  CAS  Google Scholar 

  24. Silva MA, Deen KI, Fernando DJ, Sheriffdeen A H (2002). The internal jugular vein valve may have a significant role in the prevention of venous reflux: evidence from live and cadaveric human subjects. Clin. Physiol. Funct. Imaging 22: 202–5

    Article  PubMed  CAS  Google Scholar 

  25. Chou CH, Chao AC, et Hu H (2002). Ultrasonographic evaluation of vertebral venous valves. AJNR Am. J. Neuroradiol 23: 1418–20

    PubMed  Google Scholar 

  26. Valdueza JM, von Munster T, Hoffman O et al. (2000). Postural dependency of the cerebral venous outflow. Lancet 355: 200–1

    Article  PubMed  CAS  Google Scholar 

  27. Simka M, Kostecki J, Zaniewski M et al. (2010) Extracranial Doppler sonographic criteria of chronic cerebrospinal venous insufficiency in the patients with multiple sclerosis. Int Angiol. 29: 109–14

    PubMed  CAS  Google Scholar 

  28. Zivadinov R, Marr K, Cutter G et al. (2011) Combined transcranial et extracranial venous Doppler evaluation (CTEVD) study. Description of the design and interim results of an epidemiological study of the prevalence of chronic cerebrospinal venous insufficiency in MS and related diseases. Neurology in press.

    Google Scholar 

  29. Doepp F, Paul F, Valdueza JM et al. (2010) No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol. 68: 173–83

    PubMed  Google Scholar 

  30. Mayer CA, Pfeilschifter W, Lorenz MW et al. (2011) The perfect crime? CCSVI not leaving a trace in MS J Neurol Neurosurg Psychiatry. 82: 436–40

    Article  PubMed  Google Scholar 

  31. Baracchini C, Perini P, Calabrese M et al. (2011) No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Ann Neurol. 69: 90–9

    Article  PubMed  Google Scholar 

  32. Sundström P, Wåhlin A, Ambarki K et al. (2010) Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann Neurol. 68: 255–9

    Article  PubMed  Google Scholar 

  33. Zamboni P. (2010) Regarding “no cerebrocervical venous congestion in patients with multiple sclerosis. Intraluminal jugular septation”. Ann Neurol. 68: 969

    Article  PubMed  Google Scholar 

  34. Zivadinov R, Ramanathan M, Dwyer MG et al. (2011) Comment on “no evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset”. Ann Neurol. 69: 1062–3

    Article  PubMed  Google Scholar 

  35. Zivadinov R, Galeotti R, Hojnacki D et al. (2011) Value of MR venography for detection of internal jugular vein anomalies in multiple sclerosis: a pilot longitudinal study. AJNR Am J Neuroradiol. 2011 May; 32: 938–46

    Article  PubMed  CAS  Google Scholar 

  36. Zamboni P, Menegatti E, Weinstock-Guttman B, Zivadinov R et al. (2009) The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is Funct Neurol. 24: 133–8

    CAS  Google Scholar 

  37. Poloni G, Minagar A, Haacke EM, Zivadinov R (2011). Recent developments in imaging of multiple sclerosis. Neurologist. 17: 185–204

    Article  PubMed  Google Scholar 

  38. Lejars F (1888) Les voies de sûreté de la veine rénale. Bull Soc Anat (Paris) 63e année 5e série; 504–11

    Google Scholar 

  39. Gillot C, Aaron C (1968) les voies de dérivation de la veine rénale gauche. Arch Anat pathol 16: 196–202

    Google Scholar 

  40. Kaplan HA, Browder A, Browder J (1973) Norrow and atretic transverse dural sinuses: clinical significance. Ann Otol Rhinol Laringol 82: 351–54

    CAS  Google Scholar 

  41. Zamboni P, Galeotti R, Menegatti E et al. (2009) A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg. 50:n1348–58

    Article  Google Scholar 

  42. Ludyga T, Kazibudzki M, Simka M et al. (2010) Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe? Phlebology 25: 286–95

    Article  PubMed  CAS  Google Scholar 

  43. Petrov I, Grozdinski L, Kaninski GJ et al. (2011) Safety profile of endovascular treatment for chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. Endovasc Ther 18: 314–23

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unité de pathologie vasculaire 51, Hôpital Américain de Paris, 63, boulevard Victor-Hugo, 92200, Neuilly-sur-Seine, France

    M. Greiner

Authors
  1. M. Greiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Greiner, M. (2013). Traitement endovasculaire et sclérose en plaques. In: Thérapeutiques endovasculaires des pathologies veineuses. Springer, Paris. https://doi.org/10.1007/978-2-8178-0291-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0291-6_10

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0290-9

  • Online ISBN: 978-2-8178-0291-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation